BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,287,341 | -0.4% | 2,017,986 | -1.0% | 0.16% | +10.0% |
Q2 2023 | $14,345,324 | +93495.1% | 2,037,688 | +10.9% | 0.15% | -9.1% |
Q1 2023 | $15,327 | -20.0% | 1,837,854 | +10.1% | 0.16% | -22.9% |
Q4 2022 | $19,160 | -99.9% | 1,668,999 | -0.7% | 0.21% | -15.1% |
Q3 2022 | $21,182,000 | +9.8% | 1,681,189 | -7.8% | 0.25% | +16.1% |
Q2 2022 | $19,292,000 | +25.7% | 1,823,209 | +93.2% | 0.22% | +47.6% |
Q1 2022 | $15,346,000 | – | 943,792 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |